Unique ID issued by UMIN | UMIN000052409 |
---|---|
Receipt number | R000059826 |
Scientific Title | Study of absorption enhancing effect of fat-soluble vitamins by fermented milk in human subjects. |
Date of disclosure of the study information | 2023/10/04 |
Last modified on | 2024/07/08 18:05:41 |
Study of absorption enhancing effect of fat-soluble vitamins by fermented milk in human subjects.
Study of absorption enhancing effect of fat-soluble vitamins by fermented milk in human subjects.
Study of absorption enhancing effect of fat-soluble vitamins by fermented milk in human subjects.
Study of absorption enhancing effect of fat-soluble vitamins by fermented milk in human subjects.
Japan |
Healthy subjects
Adult |
Others
NO
To confirm whether the intake of fermented milk enhances the absorption of fat-soluble vitamins in human subjects.
Bio-availability
Plasma fat-soluble vitamins and their metabolites concentrations
Plasma GLP-2 concentrations
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
2
Prevention
Food |
Subjects receive a single dose of fat-soluble vitamins + water. After the washout period (13 days or more), subjects receive a single dose of fat-soluble vitamins + fermented milk.
Subjects receive a single dose of fat-soluble vitamins + fermented milk. After the washout period (13 days or more), subjects receive a single dose of fat-soluble vitamins + water.
20 | years-old | <= |
35 | years-old | >= |
Male
1) Subjects giving written informed consent
2) Males aged 20 to 35 years old when consent acquisition
3) Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2
1) Subjects who routinely use pharmaceuticals, quasi-drugs, dietary supplement, and consume food for specified health uses, supplements containing fat-soluble vitamins more than two days per week
2) Subjects who have chronic diseases necessitating treatments and/or medications
3) Subjects who have abnormal lipid metabolism, glucose metabolism, liver function, or kidney function
4) Subjects who received digestive surgical procedures
5) habitual smokers
6) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period
7) Subjects who have food allergy
8) Subjects who is conscious of being prone to diarrhea from dairy products
9) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month
10) Subjects who determine ineligible by the principal investigator or sub-investigator
10
1st name | Yoshitatsu |
Middle name | |
Last name | Ichihara |
Meiji Co., Ltd.
Food Microbiology and Function Research Laboratories, R&D Division
1920919
1-29-1 Nanakuni, Hachioji, Tokyo
042-632-5838
yoshitatsu.ichihara@meiji.com
1st name | Masashi |
Middle name | |
Last name | Morifuji |
Meiji Co., Ltd.
Food Microbiology and Function Research Laboratories, R&D Division
1920919
1-29-1 Nanakuni, Hachioji, Tokyo
042-632-5838
masashi.morifuji@meiji.com
Meiji Co., Ltd.
Meiji Co., Ltd.
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9005
IRB@cpcc.co.jp
NO
2023 | Year | 10 | Month | 04 | Day |
Unpublished
10
Completed
2023 | Year | 09 | Month | 19 | Day |
2023 | Year | 09 | Month | 15 | Day |
2023 | Year | 11 | Month | 01 | Day |
2023 | Year | 11 | Month | 24 | Day |
2024 | Year | 03 | Month | 31 | Day |
2023 | Year | 10 | Month | 04 | Day |
2024 | Year | 07 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059826